Marlene Freeman, MD: Getting to the Truth About SSRIs and Pregnancy (Video)
The recent FDA expert panel focused largely on the risks of SSRIs during pregnancy; Dr. Freeman weighs in on the information provided in the report.
Information for Patients: How to Interpret the Recent FDA Panel on SSRIs and Pregnancy
The recent FDA expert panel focused largely on the risks of SSRIs during pregnancy but ignored or diminished the risks associated with untreated depression in the mother.Â
Zuranolone and Breastfeeding: Emerging Data and Clinical Implications
Treatment with zuranolone, a novel oral antidepressant for postpartum depression, raises important questions for breastfeeding individuals. While recent studies show minimal transfer into breast milk, we do not yet have enough information to recommend breastfeeding while taking zuranolone.
Balancing Risks and Benefits: Making Well-Informed Decisions About Medications and BreastfeedingÂ
An individualized, collaborative approach to decision-making helps mothers navigate complex choices with confidence, ensuring the well-being of their child, while attending to their own mental health. Â
From Concept to Screenings: More Than Blue – Postpartum Depression Documentary
New documentary illuminates the faces and voices of postpartum depression across America.
You Asked: Can Zuranolone Be Used to Treat Postpartum Depression in a Mother with Bipolar Disorder?
While zuranolone may show promise for the treatment of depressive episodes in patients with bipolar disorder, more research is needed.